East-West Hepatocellular Carcinoma Study Group

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01237132
Recruitment Status : Completed
First Posted : November 9, 2010
Last Update Posted : November 9, 2010
Information provided by:
University of Milan

Brief Summary:
The current treatment guidelines of hepatocellular carcinoma (HCC) of the American and European Associations for the Study of Liver Disease are based on the Barcelona-Clinic-Liver-Cancer classification (BCLC), which does not recommend surgery in patients with large, multinodular and macrovascular invasive disease. The aim of this study was to investigate the role of hepatic resection in a large retrospective multicentric cohort of patients resected for HCC regardless of the BCLC indications.

Condition or disease
Carcinoma, Hepatocellular

Study Type : Observational
Observational Model: Cohort
Time Perspective: Retrospective

Primary Outcome Measures :
  1. Overall survival of resected patients for HCC
    The primary endpoint of the study was the overall survival of patients resected for HCC in any stage of the BCLC classification.

Secondary Outcome Measures :
  1. Disease-free survival of resected patients for HCC
    The secondary endpoint was the disease-free survival of patients resected for HCC among the BCLC stages.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients affected by HCC

Inclusion Criteria:

  • clinical diagnosis of hepatocellular carcinoma
  • candidate to liver resection as a curative treatment

Exclusion Criteria:

  • uncertain diagnosis of hepatocellular carcinoma
  • uncertain follow-up data

Responsible Party: GUIDO TORZILLI MD, PHD, UNIVERSITY OF MILAN Identifier: NCT01237132     History of Changes
Other Study ID Numbers: HCC EWE
First Posted: November 9, 2010    Key Record Dates
Last Update Posted: November 9, 2010
Last Verified: December 2009

Additional relevant MeSH terms:
Carcinoma, Hepatocellular
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Liver Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Liver Diseases